NEWS

Feds Taking “Stock” of Curaleaf

 

U.S.-based medical and cannabis operator, Curaleaf, finds itself in more problems since the Food and Drug Administration (FDA) publicized that the firm was making unsubstantial health claims about its products. While the CuraLeaf did remove all claims after being warned by the federal agency, it has now been accused of violating federal securities law. Simply put, Curaleaf’s health claims is reasoned as a securities violation because the spreading of falsified material is trusted as a scheme to increase the firm’s securities market prices.

RECENTLY FEATURED IN NEWS

Speaking of Jobs Openings

Cannabis recruiting company Vangst just released its 2019 annual salary guide and as expected, as more states legalize medical or recreational cannabis sales, and nascent

Read More »

Apple Deletes Vape Apps

Apple has removed 181 vaping-related apps from its App Store. The move comes amid growing concern over the health effects of e-cigarettes and the rise

Read More »

Mutant Marijuana From Space!

Mission looks at zero gravity effects on cannabis strain development Front Range Biosciences, an agricultural technology company focused on  breeding and nursery production of new

Read More »